Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morfini

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia AM Franchini, D Girelli, O Olivieri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 1, 1999
Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosisF Baudo, T M Caimi, R Redaelli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia AJ Di Paola, M P Smith, R Klamroth, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 7, 2012
Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysisU Martinowitz, A Shapiro, D V Quon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 6, 2013
Models for institutional and professional accreditation of haemophilia centres in ItalyG Calizzani, S Vaglio, R Arcieri, et al.
Thrombosis and Haemostasis|April 26, 2014
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effectM Morfini, A Batorova, G Mariani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 7, 2013
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implicationsE Romano, M Manetti, F Peruzzi, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Experiences with continuous infusion of recombinant activated factor VIIS Schulman, R d'Oiron, U Martinowitz, et al.
Seminars in Arthritis and Rheumatism|April 18, 2003
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosisMarco Matucci Cerinic, G Valentini, G G Sorano, et al.
Thrombosis and Haemostasis|July 15, 2000
Hereditary thrombocytopenia due to reduced platelet production--report on two families and mutational screening of the thrombopoietin receptor gene (c-mpl)R Tonelli, P Strippoli, A Grossi, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia AM Franchini, D Girelli, O Olivieri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 1, 1999
Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosisF Baudo, T M Caimi, R Redaelli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia AJ Di Paola, M P Smith, R Klamroth, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 7, 2012
Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysisU Martinowitz, A Shapiro, D V Quon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 6, 2013
Models for institutional and professional accreditation of haemophilia centres in ItalyG Calizzani, S Vaglio, R Arcieri, et al.
Thrombosis and Haemostasis|April 26, 2014
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effectM Morfini, A Batorova, G Mariani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 7, 2013
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implicationsE Romano, M Manetti, F Peruzzi, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Experiences with continuous infusion of recombinant activated factor VIIS Schulman, R d'Oiron, U Martinowitz, et al.
Seminars in Arthritis and Rheumatism|April 18, 2003
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosisMarco Matucci Cerinic, G Valentini, G G Sorano, et al.
Thrombosis and Haemostasis|July 15, 2000
Hereditary thrombocytopenia due to reduced platelet production--report on two families and mutational screening of the thrombopoietin receptor gene (c-mpl)R Tonelli, P Strippoli, A Grossi, et al.
Pageof 16